Results 31 to 40 of about 9,756 (290)

Optimal timing of salvage intratympanic steroids in idiopathic sudden sensorineural hearing loss

open access: yesLaryngoscope Investigative Otolaryngology, 2022
Salvage intratympanic steroids (ITS) works in patients with idiopathic sudden sensorineural hearing loss (ISSNHL) after failure of initial therapy, but optimal timing of administration is unknown.
Yong-zhen Wu   +8 more
semanticscholar   +1 more source

Efficacy of Intratympanic Dexamethasone Injection in Subjective Idiopathic Tinnitus- An Interventional Study [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2022
Introduction: Tinnitus is a common and annoying symptom characterised by the perception of sound without any corresponding external stimulus. Subjective idiopathic tinnitus is a subjective form of tinnitus where the perceived sound originates from the ...
KR Radhakrishnan   +3 more
doaj   +1 more source

Low-Dose Intratympanic Gentamicin for Unilateral Ménière‘s Disease: Accuracy of Early Vestibulo-Ocular Reflex Gain Reduction in Predicting Long-Term Clinical Outcome

open access: yesFrontiers in Neurology, 2022
Background The number of intratympanic gentamicin (ITG) injections needed to achieve vertigo control in patients with intractable Ménière's disease (MD) may vary from a single dose to several instillations.
Ricardo Wegmann-Vicuña   +5 more
semanticscholar   +1 more source

Safety and audiological outcome in a case series of tertiary therapy of sudden hearing loss with a biodegradable drug delivery implant for controlled release of dexamethasone to the inner ear

open access: yesFrontiers in Neuroscience, 2022
BackgroundIntratympanic injections of glucocorticoids have become increasingly common in the treatment of idiopathic sudden sensorineural hearing loss (ISSHL).
Stefan K. Plontke   +5 more
doaj   +1 more source

International consensus (ICON) on treatment of Ménière's disease [PDF]

open access: yes, 2018
Objective: To present the international consensus for recommendations for Ménière's disease (MD) treatment. Methods: Based on a literature review and report of 4 experts from 4 continents, the recommendations have been presented during the 21st IFOS ...
Barbara M   +5 more
core   +1 more source

Intratympanic Administration of Dieckol Prevents Ototoxic Hearing Loss

open access: yesMarine Drugs, 2022
Objective. Systemic administration of dieckol reportedly ameliorates acute hearing loss. In this study, dieckol was delivered to the inner ear by the intratympanic route.
Hui Li   +3 more
semanticscholar   +1 more source

Nanoparticle drug delivery systems for inner ear therapy: An overview [PDF]

open access: yes, 2017
open7noembargoed_20180701Valente, Filippo; Astolfi, Laura; Simoni, Edi; Danti, Serena; Franceschini, Valeria; Chicca, Milvia; Martini, AlessandroValente, Filippo; Astolfi, Laura; Simoni, Edi; Danti, Serena; Franceschini, Valeria; Chicca, Milvia; Martini,
Astolfi, Laura   +6 more
core   +2 more sources

Intralabyrinthine Vestibular Schwannoma Responsive to Intratympanic Gentamicin Treatment [PDF]

open access: yes, 2017
Intralabyrinthine schwannoma (ILS) is a rare benign tumor that affects the ends of cochlear and vestibular nerves. In a majority of the cases, it occurs with unilateral progressive sensorineural hearing loss.
Barbara, Maurizio   +6 more
core   +1 more source

Intratympanic vs Systemic Corticosteroids in First-line Treatment of Idiopathic Sudden Sensorineural Hearing Loss: A Systematic Review and Meta-analysis.

open access: yesJAMA Otolaryngology - Head and Neck Surgery, 2020
Importance To our knowledge, evidence-based recommendations on the intratympanic vs systemic administration of corticosteroids for the treatment of idiopathic sudden sensorineural hearing loss remain unestablished, and contradictory conclusions have been
C. Mirian, T. Ovesen
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy